The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Metabolomic analysis of pegylated arginine deiminase treatment in patients with malignant pleural mesothelioma.
Essam Ahmed Ghazaly
No relevant relationships to disclose
Phuong Luong
No relevant relationships to disclose
Magdalena Chmielewska-Kassassir
No relevant relationships to disclose
Lucyna Wozniak
No relevant relationships to disclose
John S. Bomalaski
Employment or Leadership Position - Polaris
Stock Ownership - Polaris
John G. Gribben
No relevant relationships to disclose
Peter Wojciech Szlosarek
No relevant relationships to disclose